Oncology/Hematology

Brain Cancer

Latest AI and machine learning research in brain cancer for healthcare professionals.

7,568 articles
Stay Ahead - Weekly Brain Cancer research updates
Subscribe
Browse Categories
Showing 221-240 of 7,568 articles

Machine learning-based disentanglement of meteorological and anthropogenic drivers of ozone pollution in the Chengdu-Chongqing urban agglomeration.

To clarify the relative contributions of meteorological conditions and anthropogenic activities to ozone (O3) pollution in the Chengdu-Chongqing urban agglomeration, this study systematically quantified their impacts on the daily maximum 8-h average ozone concentration (O3-8 h) during 2015-2024. Using ground-based observations and ERA5-Land reanalysis data, we combined the Light Gradient Boosting ...

Apr 28 2026 42047735

Beyond binary classification: a pilot study of imaging-derived glioma severity modeling using T1-weighted and diffusion MRI radiomics.

OBJECTIVE: Gliomas are heterogeneous brain tumors with variable biology and treatment response. Accurate, non-invasive assessment of tumor aggressiveness is essential for prognosis and treatment planning. Conventional machine learning (ML) approaches typically frame glioma grading as a discrete classification task, which may overlook substantial intra-grade heterogeneity. This pilot study explores...

Apr 28 2026 42047736
Glioblastoma region-specific metabolic signatures reflect patient survival duration.

PURPOSE: Spatial metabolic differences found in glioblastoma (GBM) tumor core (contrast enhancing) and peritumoral (T2/FLAIR hyperintense) edge tissue...

Apr 28 2026 42047952
Face aging rate quantifies change in biological age to predict cancer outcomes.

Chronological age predicts cancer survival but does not capture differences in biological aging rates. We apply FaceAge, an artificial intelligence al...

Apr 28 2026 42049711
Beyond HLA-Ia: A multidimensional framework for Neoantigen immunotherapy.

Glioblastoma (GBM) and other malignant gliomas are associated with aggressive progression, high recurrence rates, and poor long-term outcomes, while c...

Apr 27 2026 42061113
Multi-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma.

BACKGROUND: Glioblastoma (GBM) is one of the most aggressive brain tumors with a poor prognosis despite current treatment modalities. This study aimed...

Apr 27 2026 42046521
Assessing large language models in radiation risk communication: susceptibility, cultural-linguistic effects, and ethical reasoning.

PURPOSE: To assess the extent to which large language models (LLMs) amplify or attenuate inaccurate or contested narratives in radiation contexts and ...

Apr 27 2026 42041146
A methodological assessment of information complementarity between MRI and GAN-based synthetic PET for multimodal medical image analysis.

Multimodal medical imaging aims to enhance analysis by combining complementary anatomical and functional information. However, access to functional mo...

Apr 27 2026 42045462
A macrophage co-expression signature enables robust prognostic prediction in glioblastoma.

BACKGROUND: Glioblastoma (GBM) exhibits profound cellular heterogeneity and a highly immunosuppressive microenvironment in which tumor-associated macr...

Apr 25 2026 42035563
Evaluating the Utility and Limitations of Machine Learning Tumor Segmentation for Automated Longitudinal RANO Treatment Response Classification.

PURPOSE: Machine learning segmentation has emerged in tumor assessment with high performance in volumetric evaluation of brain tumors. It is unclear, ...

Apr 25 2026 42034563
Enhanced ResU-Net for brain tumor segmentation using EfficientNetB0, Channel Attention, and ASPP.

Accurate and efficient segmentation of brain tumors is critical for diagnosis, treatment planning, and monitoring in clinical practice. In this study,...

Apr 24 2026 42030976
3D vessel reconstruction from sparse-view dynamic DSA images via vessel probability guided attenuation learning.

Digital Subtraction Angiography (DSA) is one of the gold standards for vascular disease diagnosis. With the help of a contrast agent, time-resolved 2D...

Apr 23 2026 42030629
Methodological appraisal practices in AI-Based radiomics research in paediatric brain tumour Imaging: A Meta-Research study of systematic reviews.

BACKGROUND: Artificial intelligence-based radiomics offers a potential adjunct to the current clinical management of paediatric brain tumours by enabl...

Apr 23 2026 42030719
AI-driven navigated hematoma aspiration vs. conservative treatment for spontaneous intracerebral hemorrhage: study protocol for a randomized controlled trial.

BACKGROUND: Spontaneous intracerebral hemorrhage (ICH) remains one of the most devastating types of stroke, with high mortality and long-term disabili...

Apr 23 2026 42021277
Fast Occupational Upper-Limb Radiation Dose Prediction Using Machine Learning and Monte Carlo Simulation.

OBJECTIVE: Interventional procedures expose physicians to scattered radiation, particularly to their upper extremities, posing occupational health ris...

Apr 23 2026 42025179
Enhancing mesenteric vascular imaging with dual-energy CTA: a comparison of DLIR and ASIR-V using low contrast agent and low radiation dose protocols.

BACKGROUND: Timely diagnosis of mesenteric vascular diseases, especially acute mesenteric ischemia (AMI) due to embolism in the superior mesenteric ar...

Apr 22 2026 42021174
A Simulation-Free Radiation Therapy Workflow Using Synthetic Computed Tomography Generated from Diagnostic Magnetic Resonance Imaging for Personalized Hippocampal-Sparing Whole-Brain Treatment.

PURPOSE: The conventional computed tomography (CT)-based consultation to simulation process for hippocampal-sparing whole-brain radiation therapy (HS-...

Apr 22 2026 42024055
The University of Texas Southwestern Glioma Dataset - MRI, Molecular Markers and Segmentations.

Gliomas are the most common type of primary brain tumors. Their management options and outcomes depend significantly on the underlying molecular-marke...

Apr 22 2026 42020453
FDA-authorized oncology artificial intelligence and machine learning devices and their clinical evidence: A cross-sectional analysis.

BACKGROUND: Artificial intelligence (AI) and machine learning (ML) tools are increasingly embedded in cancer care, yet the scope of U.S. Food and Drug...

Apr 21 2026 42025919
Browse Categories